BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19319796)

  • 21. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
    Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G
    Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for early death in transient myeloproliferative disorder without phenotypic features of Down syndrome: a case report and literature review.
    Kawase K; Azuma E; Ohshita H; Tanaka T; Hanada Y; Sasaki T; Sugimoto M; Togawa T; Kouwaki M; Ito T; Hirayama M; Koyama N
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):475-9. PubMed ID: 22510770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down's syndrome with transient myeloproliferative disorder.
    Dhaded SM; Das R; Kumar P; Narang A
    Indian Pediatr; 1996 Nov; 33(11):964-6. PubMed ID: 9141835
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombocythemia in the myeloproliferative disorder of Down's syndrome.
    Miller JM; Sherrill JG; Hathaway WE
    Pediatrics; 1967 Nov; 40(5):847-50. PubMed ID: 4229443
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinicopathological features of transient myeloproliferative syndrome and congenital leukaemia.
    Sajid N; Ahmed N; Mahmood S
    J Coll Physicians Surg Pak; 2010 Sep; 20(9):576-80. PubMed ID: 20810047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient myeloproliferative disease: keeping a high index of suspicion.
    King ME; Hueckel R
    J Pediatr Oncol Nurs; 2012; 29(5):289-93. PubMed ID: 22907684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute megakaryoblastic leukemia in Down syndrome.
    Hitzler JK
    Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute leukemias in children with Down syndrome.
    Zwaan MC; Reinhardt D; Hitzler J; Vyas P
    Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A newborn infant with Down syndrome and acute myeloid leukemia. Diagnostic difficulties between the malignant form and the myeloproliferative syndrome].
    Cominetti M; Rasore-Quartino A; Acutis MS; Vignola G
    Pathologica; 1985; 77(1052):625-30. PubMed ID: 2950370
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
    Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
    J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tzanck smear for quick screening of transient myeloproliferative disorder in neonates with vesiculopapular eruptions.
    Patel T; Patel AB; Moody M; Kelly B; Gibson B
    Int J Dermatol; 2015 Jul; 54(7):e251-3. PubMed ID: 24738623
    [No Abstract]   [Full Text] [Related]  

  • 32. Prenatal diagnosis of a transient myeloproliferative disorder in trisomy 21.
    Baschat AA; Wagner T; Malisius R; Gembruch U
    Prenat Diagn; 1998 Jul; 18(7):731-6. PubMed ID: 9706656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Congenital leukaemia and transient myeloproliferative disorder: diagnostic difficulties--case reports].
    Jackowska T; Steczowicz M; Pawelec K; Pacholska J
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):595-601. PubMed ID: 17317890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin expression in the liver with severe perisinusoidal fibrosis: autopsy case of Down syndrome with transient myeloproliferative disorder.
    Tokairin T; Nishikawa Y; Watanabe H; Doi Y; Omori Y; Yoshioka T; Yamamoto Y; Yoshida M; Nishimura T; Li Q; Arai H; Ishida A; Takada G; Enomoto K
    Pathol Int; 2008 Jan; 58(1):64-8. PubMed ID: 18067644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient leukemia-associated pericardial tamponade in a neonate with Down syndrome.
    Buyukkale G; Cetinkaya M; Akcay A; Payaslı M; Oztarhan K; Ozbek AS; Kavuncuoglu S
    Pediatr Hematol Oncol; 2012 May; 29(4):386-8. PubMed ID: 22568804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diffuse liver fibrosis associated with transient myeloproliferative disorder in Down's syndrome].
    Villamor Zambrano E; Alonso Ortiz T; Arizcun Pineda J; Moro Serrano M
    An Esp Pediatr; 1997 Jul; 47(1):69-70. PubMed ID: 9382333
    [No Abstract]   [Full Text] [Related]  

  • 37. Transient abnormal myelopoeisis in newborns with Down syndrome.
    Zarina AL; Hamidah A; Yong SC; Rohana J; Hamidah NH; Azma RZ; Boo NY; Jamal R
    Malays J Pathol; 2007 Dec; 29(2):107-11. PubMed ID: 19108403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myeloproliferative disorders and leukemia related to Down syndrome. Report of two clinical cases in neonatal period].
    Castro MX; Aristizabal AM; Aristizabal C; Llanos N; Jaramillo ML
    Arch Argent Pediatr; 2022 Apr; 120(2):e89-e92. PubMed ID: 35338823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of dysplastic platelets by peripheral blood megakaryoblasts in transient myeloproliferative disorder in Down syndrome.
    Chopra A; Kumar R; Kabra M; Anand M
    Platelets; 2008 Mar; 19(2):160-1. PubMed ID: 18297553
    [No Abstract]   [Full Text] [Related]  

  • 40. Down syndrome and the myeloproliferative disorder.
    Amendola G; Amato L; Cirillo G; Dante G
    Clin Pediatr (Phila); 1990 Aug; 29(8):486. PubMed ID: 2145112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.